Aurora Cannabis: Remarkable Recovery
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB stock from hold to buy.
Aurora Cannabis Skyrockets but Don’t Fight its Bearish Trend
Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also suggests that the stock is experiencing more of a short cover rally instead of a fundamental directional change. From a technical perspective, investors should expect to see today's 40% increase fade over the next 4-6 weeks.
Aurora Cannabis price target raised to C$10 from C$9 at TD Securities
TD Securities raised the firm’s price target on Aurora Cannabis (ACB) to C$10 from C$9 and keeps a Buy rating on the shares.Maximize Your
Aurora Cannabis (ACB) Q3 2025 Earnings Call Transcript
Operator Greetings, and welcome to the Aurora Cannabis Inc. third quarter 2025 results conference call. [Operator instructions] This conference call is being recorded today, Wednesday, February 5, 2025.
Aurora Cannabis Shines: Earnings Call Highlights
Aurora Cannabis (US) (($TSE:ACB)) has held its Q3 earnings call. Read on for the main highlights of the call. The latest earnings call from Aurora
Aurora Cannabis price target raised to C$12.50 from C$10 at Canaccord
Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your
Aurora Cannabis boosts Canadian peers after Q3 beat
Shares of Canadian cannabis companies, including Canopy Growth (NASDAQ:CGC) and Tilray Brands (NASDAQ:TLRY), surged on Wednesday after their peer Aurora Cannabis (NASDAQ:ACB) reported better-than-expected revenue for Q3 fiscal 2025.
Aurora Cannabis Announces Supply Agreement with SNDL
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis ...
Aurora Cannabis jumps as medical cannabis drives Q3 beat
Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...
Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos?
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Aurora Cannabis Third Quarter 2025 Earnings: EPS: CA$0.57 (vs CA$0.51 loss in 3Q 2024)
CA$31.6m (up from CA$24.2m loss in 3Q 2024). Profit margin: 36% (up from net loss in 3Q 2024). EPS: CA$0.57 (up from CA$0.51 ...
Aurora Cannabis Launches Its First Germany-Made Medical Cannabis Brand
Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading ...
Aurora Cannabis Announces Fiscal 2025 Third Quarter Results
CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...
Cannabis stocks extend gains on RFK Jr. committee vote, Senate banking comments
Robert F. Kennedy Jr., seen as pro-cannabis, is heading toward expected approval as Health and Human Services secretary, ...
TLRY, CGC: Cannabis Stocks Rally on Aurora’s Strong Earnings
Cannabis stocks Tilray (TLRY) and Canopy Growth (CGC) rallied 7% and 22.2%, respectively, on Wednesday. One of the key drivers of this upside ...